🇺🇸 FDA
Patent

US 8912198

Compounds useful as inhibitors of ATR kinase

granted A61PA61P35/00

Quick answer

US patent 8912198 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P35/00